Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LuCa-MERIT-1: First-in-human, Open Label, Phase I Dose Confirmation Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer

NCT05142189 is registered in ClinicalTrials.gov with BioNTech SE as lead sponsor.

NCT NCT05142189
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05142189 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LuCa-MERIT-1: First-in-human, Open Label, Phase I Dose Confirmation Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer
Lead sponsor
BioNTech SE
Phase
Phase 1
Overall status
Recruiting
Start date
June 17, 2022
Completion date
November 30, 2031
Enrollment
320 (estimated)
Sites
45

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer